Chandra Bhagat Pharma Limited (BOM:542934)

India flag India · Delayed Price · Currency is INR
36.58
-1.92 (-4.99%)
At close: Mar 9, 2026
-36.93%
Market Cap 276.00M
Revenue (ttm) 493.95M
Net Income (ttm) 6.22M
Shares Out 7.55M
EPS (ttm) 0.83
PE Ratio 44.25
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,000
Average Volume 8,500
Open 36.58
Previous Close 38.50
Day's Range 36.58 - 36.58
52-Week Range 33.00 - 68.99
Beta -0.76
RSI 36.61
Earnings Date Feb 12, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1944
Employees 40
Stock Exchange Bombay Stock Exchange
Ticker Symbol 542934
Full Company Profile

Financial Performance

In fiscal year 2025, Chandra Bhagat Pharma's revenue was 887.67 million, a decrease of -60.11% compared to the previous year's 2.23 billion. Earnings were 8.58 million, a decrease of -43.95%.

Financial Statements

News

There is no news available yet.